Treatment of Mice Bearing a Second Variant of Intracranial Glioma (GL261) or Melanoma (B16-F10) Tumors with Ad-Flt3L and Ad-TK (+GCV) Results in Long-Term Survival and Increased Serum Levels of HMGB1. The gene discussed is HMGB1; the disease is melanoma.